Idamycin
Showing 26 - 37 of 37
Recurrent Adult Acute Myeloid Leukemia Trial in Palo Alto (Cytarabine, Ibrutinib, Idarubicin)
Terminated
- Recurrent Adult Acute Myeloid Leukemia
- Cytarabine
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
May 7, 2018
CAMS(Chinese Academy of Medical Sciences)-2005 Trial and
Completed
- Acute Myeloid Leukemia, Pediatric
- Risk-stratified therapy
-
Tianjin, Tianjin, ChinaInstituteHBDH
May 24, 2017
Leukemia, Myeloid Trial in Beijing (hematopoietic stem cell)
Unknown status
- Leukemia, Myeloid
- hematopoietic stem cell
-
Beijing, Beijing, ChinaAffiliated Hospital of Academy of Military Medical Sciences ,
Mar 30, 2017
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +12 more
- Lenalidomide
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 22, 2014
Leukemia Trial in Worldwide (biological, drug, radiation)
Completed
- Leukemia
- filgrastim
- +13 more
-
Tucson, Arizona
- +57 more
Jul 24, 2014
Leukemia Trial in Worldwide (filgrastim, cladribine, idarubicin)
Completed
- Leukemia
- filgrastim
- +2 more
-
Birmingham, Alabama
- +234 more
Jul 24, 2014
GVHD, Leukemia, MDS Trial in Houston (biological, drug, procedure)
Completed
- Graft Versus Host Disease
- +2 more
- Filgrastim
- +7 more
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Jul 27, 2012